Why Are Analysts Bullish on Regeneron Pharmaceuticals, Inc. (REGN) Now?
We recently compiled a list of the 12 Best S&P 500 Stocks to Invest in According to Analysts. In this article, we are going ...
Regeneron Is Playing Defense With Capital Allocation
Regeneron's 2025 outlook includes defensive capital allocation, competitive pressure on Eylea, et cetera. Click here to read ...
Bellevue startup, armed with $320 million, undertakes ambitious project to aid medical research
Regeneron, San Diego-based biotech company Illumina and 17 health systems invested in the $320 million round. Regeneron ...
Regeneron beats quarterly estimates on eczema drug demand; launches dividend program
Regeneron Pharmaceuticals beat fourth-quarter sales and profit estimates on Tuesday, on continuing demand for its eczema ...
Yahoo Finance13d
Why Are Analysts Bullish on Regeneron Pharmaceuticals, Inc. (REGN) Now?
In this article, we are going to take a look at where Regeneron Pharmaceuticals ... which posted a gain of 23.31%, building on the 24.2% return in 2023. The two-year surge of over 53% is the ...
U.S. News & World Report11d
Regeneron Beats Quarterly Estimates on Eczema Drug Demand; Launches Dividend Program
(Reuters) - Regeneron Pharmaceuticals beat fourth-quarter sales and profit estimates on Tuesday, on continuing demand for its eczema treatment, Dupixent, and announced a dividend and stock buyback ...